Brief: Biotec Pharmacon Says Results From Neuroblastoma Phase II Vaccine Study Indicate Promising Adjuvant (SBG) Effect

Arcticzymes Technologies ASA

14/05/2018 01:27

May 13 (Reuters) - Biotec Pharmacon ASA  BIOTEC.OL :
    * RESULTS FROM NEUROBLASTOMA PHASE II VACCINE STUDY INDICATE
PROMISING ADJUVANT (SBG) EFFECT

Source text for Eikon:  ID:nWkr79L4TZ 
Further company coverage:  BIOTEC.OL 

 ((Reuters.Briefs@thomsonreuters.com;))